Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00892957 · ClinicalTrials.gov registry record · Phase 3
FS VH S/D 500 S-apr in Vascular Surgery
A Phase 3 study, sponsored by Baxter Healthcare Corporation.
- Completed
- Registry status
- Phase 3
- Development phase
- 176
- Enrollment target
NCT00892957 is a Phase 3 study that has completed, run by Baxter Healthcare Corporation. The registered enrollment target is 176 participants.
The verdict
NCT00892957, a Phase 3 study, has completed, sponsored by Baxter Healthcare Corporation.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 176 participants
- Enrollment target
Study Summary
The purpose of this study was to compare safety and efficacy of FS VH S/D 500 s-apr (FS) versus manual compression in prosthetic expanded polytetrafluoroethylene (ePTFE) graft placement.
Interventions
- BIOLOGICAL Fibrin Sealant, Vapor Heated, Solvent/Detergent-treated with 500 IU/ml thrombin and synthetic aprotinin (FS VH S/D 500 s-apr)
- OTHER Surgical gauze pads
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 176 participants |
| Start Date | 2009-07 |
| Est. Completion | 2010-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00892957
The ClinicalTrials.gov registry entry for NCT00892957 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 176 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baxter Healthcare Corporation, which has 46 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Fibrin Sealant, Vapor Heated, Solvent/Detergent-treated with 500 IU/ml thrombin and synthetic aprotinin (FS VH S/D 500 s-apr) is the first listed.
NCT00892957 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00892957 about?
NCT00892957 is a clinical study titled "FS VH S/D 500 S-apr in Vascular Surgery". The purpose of this study was to compare safety and efficacy of FS VH S/D 500 s-apr (FS) versus manual compression in prosthetic expanded polytetrafluoroethylene (ePTFE) graft placement.
What is the current status of trial NCT00892957?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 176 participants. The study started on 2009-07. Estimated completion is 2010-11.
What interventions are being tested in trial NCT00892957?
The interventions under investigation include: Fibrin Sealant, Vapor Heated, Solvent/Detergent-treated with 500 IU/ml thrombin and synthetic aprotinin (FS VH S/D 500 s-apr) (BIOLOGICAL), Surgical gauze pads (OTHER).
Who is sponsoring clinical trial NCT00892957?
This trial is sponsored by Baxter Healthcare Corporation, which has 46 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.